New depression drug shows promise in Mid-Stage trial
Symptom relief
Completed
This study tested a new medicine, NH102, for people with major depression. 243 adults took part to see if it helps reduce depression symptoms compared to a placebo or an existing drug (duloxetine). The goal is to find the right dose and check safety before moving to larger studie…
Phase: PHASE2 • Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC